Seed VC · Wakefield, United Kingdom
Epidarex Capital is a venture capital firm specializing in early-stage investments in life sciences and healthcare companies, with a focus on the UK and US markets. Founded in 2010 and headquartered in Edinburgh, Scotland, the firm partners with top universities and research institutions to commercialize innovative medical technologies and therapeutics. Epidarex is known for supporting spinouts and startups in underserved regions, helping to bridge the gap between academic research and commercial success. The firm has a strong track record of building companies that attract significant follow-on funding and has contributed to the growth of the biotech sector in its target markets.
Business models
biotech_therapeutics, deeptech_ip, hardware
Customer segments
Researchers, Healthcare providers, Pharmaceutical companies
Geography
UK, US
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Epidarex Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VCboom tracks Epidarex Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Epidarex Capital is one of them — and we'll tell you exactly where they sit in your top 100.